On the usefulness of four in vitro methodologies in screening for product related differences in tacrolimus exposure after oral administration of amorphous solid dispersions with modified release characteristics in the fasted state

Simple item page
dc.check.date2022-12-11
dc.check.infoAccess to this article is restricted until 12 months after publication by request of the publisher.en
dc.contributor.authorTsakiridou, Georgia
dc.contributor.authorO'Dwyer, Patrick J.
dc.contributor.authorMargaritis, Antonios
dc.contributor.authorBox, Karl J.
dc.contributor.authorVertzoni, Maria
dc.contributor.authorKalantzi, Lida
dc.contributor.authorReppas, Christos
dc.contributor.funderHorizon 2020en
dc.date.accessioned2021-12-17T12:58:46Z
dc.date.available2021-12-17T12:58:46Z
dc.date.issued2021-12-11
dc.date.updated2021-12-17T12:37:39Z
dc.description.abstractObjective: To investigate the usefulness of four in vitro methodologies in screening for product related differences in tacrolimus exposure after oral administration of amorphous solid dispersions with modified release characteristics in the fasted state. Methods: Initially, Advagraf® (5 mg tacrolimus/capsule), Envarsus® (4 mg tacrolimus/tablet) and a modified release Test Tablet (5 mg tacrolimus/tablet) were subjected to in vitro biorelevant performance testing simulating fasted state conditions using a small-scale two-stage biphasic system, a small-scale two-stage dissolution – permeation (D-P) system, the compendial apparatus IV (open loop mode) and the biorelevant gastrointestinal transfer (BioGIT) system. Early and total exposure, after single dose administrations of the three products to twelve healthy adults in the fasted state on a crossover basis, were then evaluated. Subsequently, the usefulness of in vitro data in qualitatively predicting product related differences in early exposure and in total exposure were assessed. Results: Product related differences in tacrolimus early exposure were successfully predicted by data collected with compendial apparatus IV. The two-stage biphasic system was useful for predicting differences in early exposure between the non-disintegrating Envarsus® and the disintegrating products (Advagraf® or Test Tablet). BioGIT data were useful only for discussing clinical data early after administration of the two disintegrating products. Prediction of product related differences in total exposure was successful only when the compendial apparatus IV was used for comparing the two disintegrating products. Conclusions: Biorelevant in vitro performance testing with compendial apparatus IV was useful for qualitatively predicting differences in tacrolimus early and total exposure after administration of disintegrating products with modified release characteristics in the fasted state.en
dc.description.sponsorshipHorizon 2020 (674909)en
dc.description.statusPeer revieweden
dc.description.versionAccepted Versionen
dc.format.mimetypeapplication/pdfen
dc.identifier.citationTsakiridou, G., O'Dwyer, P. J., Margaritis, A., Box, K. J., Vertzoni, M., Kalantzi, L. and Reppas, C. (2021) 'On the usefulness of four in vitro methodologies in screening for product related differences in tacrolimus exposure after oral administration of amorphous solid dispersions with modified release characteristics in the fasted state', Journal of Drug Delivery Science and Technology. doi: 10.1016/j.jddst.2021.102990en
dc.identifier.doi10.1016/j.jddst.2021.102990en
dc.identifier.issn1773-2247
dc.identifier.journaltitleJournal of Drug Delivery Science and Technologyen
dc.identifier.urihttps://hdl.handle.net/10468/12353
dc.language.isoenen
dc.publisherElsevier B.V.en
dc.rights© 2021, Elsevier B.V. All rights reserved. This manuscript version is made available under the CC BY-NC-ND 4.0 license.en
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/en
dc.subjectTacrolimusen
dc.subjectAmorphous solid dispersionsen
dc.subjectModified releaseen
dc.subjectBiphasic systemen
dc.subjectDissolution-permeation systemen
dc.subjectCompendial apparatus IVen
dc.subjectBioGITen
dc.subjectEarly exposureen
dc.subjectTotal exposureen
dc.subjectAdultsen
dc.titleOn the usefulness of four in vitro methodologies in screening for product related differences in tacrolimus exposure after oral administration of amorphous solid dispersions with modified release characteristics in the fasted stateen
dc.typeArticle (peer-reviewed)en
Files
Original bundle
Now showing 1 - 2 of 2
Thumbnail Image
Name:
1-s2.0-S1773224721006705-main.pdf
Size:
2.08 MB
Format:
Adobe Portable Document Format
Description:
Accepted Version
Download
Thumbnail Image
Name:
1-s2.0-S1773224721006705-mmc1.docx
Size:
92.67 KB
Format:
Microsoft Word XML
Description:
Supplementary Data
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
2.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Pharmacy - Journal Articles